Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Benefits and expectations at the NBA

  • Home
  • Benefits and expectations at the NBA

Our people

We have a motivated workforce that helps Australians who need blood products and related services. Our team delivers significant outcomes for the Australian blood sector in a challenging and ever-changing healthcare industry.

We attract high-quality staff for the range of required disciplines across the agency. Our team includes people with expertise in administration, communications, corporate functions, data and digital technology, policy-making, regulation and compliance.

Our employees have a track record of taking responsibility, delivering results, displaying initiative and working autonomously. 
We strive to create an environment of diversity, enthusiasm and professionalism for our employees.

Renovated office accommodation provides an attractive and practical workspace where staff and visitors can work and collaborate. Robust ICT systems and security enable people to work efficiently in the office or remotely.

Salary, benefits and conditions

Under the National Blood Authority Enterprise Agreement, we offer competitive benefits and conditions for APS levels 1 to 6 and Executive Levels (EL) 1 and 2 roles. These include:

  • 15.4% superannuation, including during periods of paid leave
  • an ordinary working week of 37.5 hours, with access to flex time and flexible working arrangements for eligible positions
  • 20 days of paid annual leave per year
  • 18 days of paid personal leave
  • paid compassionate leave, parental leave and long-service leave
  • salary packaging
  • healthy lifestyle assistance
  • employee support, including influenza vaccinations and an employee assistance program.

Other benefits include affordable onsite parking, a focus on career development and learning opportunities in diverse roles.

Enterprise agreement

The National Blood Authority provides a range of benefits and conditions set out in the National Blood Authority Enterprise Agreement 2024-2027 for non-SES employees and in individual arrangements for SES employees.

The EA has a nominal expiry date of 3 years after it started. However, it remains current until revoked and replaced by a new agreement.

  • National Blood Authority Enterprise Agreement 2024-2027
    647.38 KB

Expectations

We empower our staff to be leaders and find innovative ways to improve the lives of Australians who need blood and blood products.

We expect all our staff to:

  • perform their duties professionally and respectfully
  • achieve outcomes of the highest standard
  • reflect the best principles and practices of workplace diversity, workplace participation and a safe working environment.

All our staff are employed under the Public Service Act 1999 (Cth).

Learn more about working in the APS:

  • APS Code of Conduct(Opens in a new tab/window)
  • Cracking the code(Opens in a new tab/window)
  • Public Service Act 1999 (Opens in a new tab/window)(Cth).

Get in touch

Email: NBA.Recruitment@blood.gov.au

By post:

Human Resources
National Blood Authority
Locked Bag 8430
CANBERRA ACT 2601

Last updated: 27 Mar 2024

Back to top

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback